Cargando…
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis
BACKGROUND: Rare diseases (RDs) in rheumatology as a group have a high prevalence, but randomized controlled trials are hampered by their heterogeneity and low individual prevalence. To survey the current evidence of pharmacotherapies for rare rheumatic diseases, we conducted a systematic review and...
Autores principales: | Bender, Tim T. A., Leyens, Judith, Sellin, Julia, Kravchenko, Dmitrij, Conrad, Rupert, Mücke, Martin, Seidel, Matthias F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603763/ https://www.ncbi.nlm.nih.gov/pubmed/33129321 http://dx.doi.org/10.1186/s13023-020-01576-5 |
Ejemplares similares
-
The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis
por: Leyens, Judith, et al.
Publicado: (2021) -
Pain drawings as a diagnostic tool for the differentiation between two pain-associated rare diseases (Ehlers-Danlos-Syndrome, Guillain-Barré-Syndrome)
por: Wester, Larissa, et al.
Publicado: (2020) -
Systematic review and meta‐analysis on non‐opioid analgesics in palliative medicine
por: Schüchen, Robert H., et al.
Publicado: (2018) -
Die Rolle der ZSE und die Zusammenarbeit mit der Pädiatrie
por: Häder, Tinus, et al.
Publicado: (2021) -
Exploring different stakeholders’ perspectives on ward rounds in paediatric oncology: a qualitative study
por: Berndt, Lea P., et al.
Publicado: (2023)